RAG2 and leukemia: Thus, to examine the impact of the CD8+ lymphocytes on leukemia progression and mice survival, the cells were isolated from spleens of untreated or DT-treated TCL1 leukemia-bearing mice (the same scheme of experiment as shown in Figure 1A), and adoptively transferred into TCL1-injected RAG2-KO mice (Figure 2A).